Q2 2024 13F Holders as of 30 Jun 2024
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
10,647,547
-
Total 13F shares
-
110,906
-
Share change
-
+36,317
-
Total reported value
-
$308,337
-
Price per share
-
$2.78
-
Number of holders
-
10
-
Value change
-
+$100,958
-
Number of buys
-
7
-
Number of sells
-
1
Institutional Holders of Neuraxis, INC - Common Stock, par value $0.001 per share (NRXS) as of Q2 2024
As of 30 Jun 2024,
Neuraxis, INC - Common Stock, par value $0.001 per share (NRXS) was held by
10 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
110,906 shares.
The largest 10 holders included
VANGUARD GROUP INC, STIFEL FINANCIAL CORP, Royal Bank of Canada, CITADEL ADVISORS LLC, PARSONS CAPITAL MANAGEMENT INC/RI, GEODE CAPITAL MANAGEMENT, LLC, Tower Research Capital LLC (TRC), UBS Group AG, BANK OF AMERICA CORP /DE/, and JPMORGAN CHASE & CO.
This page lists
10
institutional shareholders reporting positions in this security
for the Q2 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.